English | Español

Biospace
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
Patient Daily | Mar 11, 2026

Servier acquires Day One Biopharmaceuticals for $2.5 billion
Patient Daily | Mar 11, 2026

FDA stands firm on sham-controlled trial requirement for uniQure's Huntington's therapy
Patient Daily | Mar 11, 2026

Johnson & Johnson receives rapid FDA approval for new multiple myeloma combination
Patient Daily | Mar 11, 2026

Roche and Zealand Pharma report mixed mid-stage results for obesity drug
Patient Daily | Mar 11, 2026

Direct-to-consumer drug sales offer limited relief for high medication costs

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures